Page 5 - Imrus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Imrus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Imrus Today - Breaking & Trending Today
Carmignac Gestion grew its holdings in shares of Merus (NASDAQ:MRUS – Free Report) by 5.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 474,652 shares of the biotechnology company’s stock after acquiring an additional 25,000 shares during the period. Carmignac Gestion owned about 1.02% of Merus worth […] ....
TD Cowen assumed coverage on shares of Merus (NASDAQ:MRUS – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating on the biotechnology company’s stock. Several other research analysts also recently issued reports on the company. Guggenheim upped their price objective on Merus from $46.00 […] ....
Merus (NASDAQ:MRUS – Get Free Report)’s share price rose 4% on Friday . The stock traded as high as $21.03 and last traded at $20.94. Approximately 46,350 shares were traded during trading, a decline of 86% from the average daily volume of 327,576 shares. The stock had previously closed at $20.13. Analysts Set New Price […] ....
Merus (NASDAQ:MRUS – Free Report) had its price target reduced by Citigroup from $48.00 to $46.00 in a research report sent to investors on Thursday morning, Benzinga reports. Citigroup currently has a buy rating on the biotechnology company’s stock. Other research analysts also recently issued reports about the company. SVB Securities lifted their target price […] ....
Merus (NASDAQ:MRUS – Get Free Report) had its target price raised by equities researchers at Guggenheim from $46.00 to $48.00 in a report issued on Tuesday, MarketBeat reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective would suggest a potential upside of 109.61% from the stock’s current price. […] ....